𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: Low incidence of HCV infection

✍ Scribed by Georgios N. Dalekos; Eleftheria Zervou; Markos H. Merkouropoulos; Epameinondas V. Tsianos


Publisher
Springer
Year
1996
Tongue
English
Weight
534 KB
Volume
12
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

✦ Synopsis


Intravenous heroin abusers comprise a high risk group for hepatitis B and C viruses (HBV and HCV) infection. Chronic alcoholics with liver disease (LD) also comprise a high risk group for HBV infection whereas the frequency of antibodies to HCV (anti-HCV) ranges from 27-42.6%. In this study, HBV and HCV infection markers were determined in alcoholic patients with (83 patients) or without LD (68 patients) in order to assess the prevalence of these markers (HBsAg, HBsAb, HBcAb and anti-HCV). The reason for the study was a lack of established data in this group of patients in Greece. The disease control groups consisted of 70 non-alcoholic hospitalized patients and 60 heroin addicts, whereas 1342 healthy blood donors were also investigated. Our results showed significantly Key words: Alcoholism, Hepatitis B virus, Hepatitis C increased prevalence of HBV infection markers in chronic alcoholic patients compared to healthy controls and non-alcoholic hospitalized patients. The findings were independent of the presence or absence of LD. In contrast to heroin addicts, where anti-HCV antibodies were observed in 90%, there was no difference in the prevalence of anti-HCV antibodies in chronic alcoholics (with or without LD), nonalcoholic hospitalized patients or healthy controls. In conclusion, we found that in this area of northwestern Greece, chronic alcoholics, independent of the presence of LD, comprise a high risk group for HBV infection but very rarely have HCV infection. The latter finding may reflect technical or socioeconomic differences regarding the lifestyle of our patients, and our population in general.


πŸ“œ SIMILAR VOLUMES


High prevalence of dual or triple infect
✍ Bira Tsatsralt-Od; Masaharu Takahashi; Tsutomu Nishizawa; Kazunori Endo; Jun Ino πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

Mongolia is known for its high endemicity for hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) infections among apparently healthy individuals. However, there are little or no data on the prevalence and genotype distribution of HBV, HCV, and HDV among patients with c

Biliary intraepithelial neoplasia in pat
✍ Tsung-Teh Wu; Michael Levy; Arlene M. Correa; Charles B. Rosen; Susan C. Abraham πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 949 KB

## Abstract ## BACKGROUND: Biliary intraepithelial neoplasia (BilIN) represents a spectrum of proliferative and/or cytologically atypical lesions of the large intrahepatic bile ducts. BilIN is believed to be a major pathway leading to the development of intrahepatic cholangiocarcinoma (CCA) throug

Virological significance of low-level he
✍ Takeshi Tanaka; Kazuaki Inoue; Yukiko Hayashi; Aki Abe; Kyoko Tsukiyama-Kohara; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

## Abstract The clinical and virological significance of low‐level viremia by hepatitis B virus (HBV) in hepatitis C virus (HCV)‐infected patients remains unclear. HBV‐DNA and HCV‐RNA were, therefore, quantitatively analyzed in livers and sera from co‐infected patients. HBV‐DNA and HCV‐RNA were qua

Antiviral treatment of chronic hepatitis
✍ George H. Scullard; Ljudevit L. Andres; Harry B. Greenberg; Joseph L. Smith; Vin πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 398 KB πŸ‘ 1 views

Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests,